Dr Laxmi Mehta, from Ohio State University, talks about how treatment options differ between men and women who present with myocardial infarction and how to prevent a subsequent infarction.
Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Dr David Nash, founding dean of the Jefferson College of Population Health, discusses the patient- and physician-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly...
Dr David Nash, founding dean of the Jefferson College of Population Health, discusses the patient- and physician-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly...
